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INTRODUCTION
The female pelvic supportive structure can be divided into three 
levels. Level 1 is cardinal-uterosacral ligament complex, and 
levels 2 and 3 consist of fascia, the urogenital diaphragm and the 
perineal body that support the middle and lower parts of the 
vagina. Among the three levels, defects at level 1 results in uter-
ine prolapse due to descent of the uterine body.1
Not all patients with uterine prolapse, however, experience 
descent of the uterine body. Cervical elongation can cause uter-
ine prolapse without descent of the uterus. In these patients, lev-
el I remains relatively intact, compared to that in uterine descent 
patients. “True cervical elongation” can be distinguished from 
uterine descent by pelvic examination. If the D point of the Pel-
vic Organ Prolapse Quantification (POP-Q) system is high and 
the C point is below the hymen, the etiology of uterine prolapse 
can be considered to be related to cervical elongation rather than 
uterine descent. 
When attempting to correct uterine prolapse by surgery, pa-
tient’s preference can affect what operation will be performed. 
While vaginal hysterectomy (VH) is one of the classical opera-
tions to treat uterine prolapse,2 some women prefer uterine pres-
ervation instead of hysterectomy at the time of pelvic organ pro-
lapse (POP) surgery.3,4
The Manchester operation is a procedure that involves exci-
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sion of the cervix and suture of the cervical stump to the car-
dinal ligament. Since the Manchester operation maintains the 
uterine body, it seems effective in correcting uterine prolapse 
caused by true cervical elongation. In contrast, the Manchester 
operation is thought to be less effective than VH in patients with 
uterine body descent.5 Nevertheless, the clinical outcomes of 
Manchester operation for patients with true cervical elongation 
is unknown. Although the success rate of Manchester operation 
for uterine descent is expected to be lower than that for cervi-
cal elongation, previous studies of the Manchester operation in-
cluded both etiologies of uterine prolapse. In addition, they in-
cluded patients who did not have uterine prolapse or women 
with POP-Q stage I that did not need surgery. In result, the report-
ed failure rates of Manchester operation vary from 0 to 50%.5-8 
The aim of this study was to investigate the clinical outcomes 
of Manchester operation in patients with true cervical elonga-
tion in comparison to VH by matching the baseline character-
istics of the patients. 
MATERIALS AND METHODS
Study population
This study was a retrospective cohort study and was approved 
by the Yonsei University Institutional Review Board (IRB 4-2017-
0499). The medical records of the patients who underwent Man-
chester operation or VH at Severance Hospital between Janu-
ary 2006 and December 2015 were reviewed.
Patients who had uterine prolapse (preoperative apical POP-
Q stage ≥2) were eligible for inclusion in this study. Women with 
normal Pap smear results and uterine anteroposterior diameters 
<4 cm, confirmed using transvaginal ultrasonography (TVS) 
before the operation, were included. We excluded patients who 
had undergone supracervical hysterectomy and women with 
missing medical records on preoperative Pap smear or TVS. All 
women who received Manchester operation expressed willing-
ness to preserve their uterus confirmed by medical interview.
During the study period, 550 patients underwent Manches-
ter operation or VH under general anesthesia. Of the 550 pa-
tients, those who underwent concurrent suspension surgery, 
including iliococcygeal colposuspension (n=80) or non-vagi-
nal surgery, such as concurrent appendectomy (n=54), were 
excluded on the basis of their surgical records. Patients who 
did not complete the follow-up visit at 1 year after operation 
were also excluded (n=19). Finally, 397 patients were eligible for 
this study: 374 patients had VH and 23 patients received Man-
chester operation (Fig. 1).
Diagnostic method of uterine prolapse caused by true 
cervical elongation
In this study, cervical elongation without uterine descent was 
confirmed by pelvic examination. On the basis of the POP-Q 
system, we confirmed uterine prolapse caused by true cervi-
cal elongation with C point ≥0, D point ≤-4, and estimated cer-
vical length ≥5 cm on pelvic examination.9 Estimated cervical 
length was calculated as the difference between the C and D 
points of the POP-Q system.
Medical records and measurement
General characteristics, such as age, body mass index (BMI), 
parity, smoking status, postmenopausal status, information 
about length of hospital stay, duration of operation, blood loss 
during surgery, and postoperative complications, were obtained 
from the review of medical records.
Experienced urogynecologists performed the pelvic exami-
nations and evaluated POP-Q stage before surgery for the en-
tire study population. All patients were required to make visits 
to the outpatient clinic at 1 year after operation and every year 
thereafter. Evaluations of POP-Q stage were obtained from every 
visit to the outpatient clinic. Recurrence was diagnosed if POP-Q 
stage was greater than stage I in pelvic examination.
Screened for eligibility (n=550)
• Apical prolapse (POP-Q) stage ≥2) and
• Normal pap smear and
• APD ≤4 cm in TVS and
• No history of suspracervical hysterectomy
Inclusion criteria for Manchester operation
• No descent of uterine body (POP-Q C point ≥0) and
•  Cervical elongation (POP-Q D point ≥-4, estimated cervical length in pel vic 
exam ≥5 cm) and
• No benign indications for hysterectomy in TVS and
• Wanted to preserve uterus
Yes
Follow up
loss (n=18)
Manchester operation (n=24)
Manchester operation (n=23)
Manchester operation (n=20)
Matched with age, parity and preoperative POP-Q stage
VH (n=392)
VH (n=374)
VH (n=20)
No
Excluded (n=134)
• Concurrent suspension surgery (n=80)
• Concurrent non-vaginal surgery (n=54)
Follow up
loss (n=1)
Fig. 1. Flow chart. POP-Q, Pelvic Organ Prolapse Quantification; APD, an-
teroposterior diameter; TVS, transvaginal ultrasonography; VH, vaginal 
hysterectomy.
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Statistical analyses
To reduce possible selection bias, the propensity score (PS) match-
ing technique was adopted. One of the data features was that 
preoperative POP-Q stage was concentrated in stage III (95% in 
Manchester operation; 90% in the VH group). Therefore, further 
analysis was conducted to focus on POP-Q stage III. The results 
of this study consisted of the following three parts: 1) the main 
results from 1:1 PS matching with age, parity, and preoperative 
POP-Q stage as matching variables producing 20 subjects in 
each group; 2) the first subgroup results from 1:1 PS matching 
with age and parity as matching variables only for the patients 
with preoperative POP-Q stage III, producing 20 subjects in each 
group; and 3) the second subgroup results only from patients 
with preoperative POP-Q stage III (n=204). The paired t test, if 
the normality assumption was met, or the McNemar test was 
used to compare continuous and categorical variables, respec-
tively, between the Manchester operation and VH groups in the 
matched data. The natural form of data (i.e., not matched) was 
analyzed using an independent t test (or Mann-Whitney U test) 
for continuous variables or chi-square test (or Fisher exact test) 
for categorical variables depending on the violations of the as-
sumptions. The results are presented as mean±standard devi-
ation or median (Q1, Q3) and counts with percentages in paren-
theses for continuous and categorical variables, respectively. 
The third part presents the logistic regression analysis results. 
In the univariate logistic regression, some of the variables, such 
as postmenopausal status, in the Manchester operation group 
were not estimated well owing to rare events; therefore, Firth’s 
bias correction was used to resolve the situation. A multivariable 
logistic regression model was developed choosing the signifi-
cant variables in the univariate logistic regression. All statistical 
tests were two-sided, and p values <0.05 were considered statis-
tically significant. All analyses were performed using SAS ver-
sion 9.4 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Of the baseline characteristic, BMI, postmenopausal status, and 
smoking history were not statistically different between Man-
chester operation and VH groups after PS matching with age, par-
ity, and preoperative POP-Q stage variables. All subjects in-
cluded in this study had advanced stages of POP that were 
preoperative POP-Q stage III or IV after matching. All patients 
in both groups underwent posterior colporrhaphy. The rate of 
concurrent anterior colporrhaphy was not statistically signifi-
cantly different between the two groups (Table 1).
Table 2 shows the surgical outcomes of Manchester operation 
and VH. After matching, no recurrence of POP was reported in 
the Manchester operation group, and one case of POP recur-
rence was confirmed on pelvic examination in the VH group. 
No statistically significant difference in the recurrence rates of 
POP was found between the Manchester operation and VH 
groups. The duration of hospital stay and blood loss during sur-
gery were not significantly different between the two groups. 
Manchester operation had shorter operation time by about 14 
minutes than the VH procedure (95.3 vs. 109.1 minutes, p=0.033). 
No statistically significant difference in postoperative complica-
tion rates was found between the Manchester operation and 
VH groups.
Tables 3 and 4 show the results of the subgroup analysis per-
formed using the PS matching method with age, BMI, and par-
ity as matching variables for patients with preoperative POP-Q 
stage III. No significant difference in the recurrence rate of POP 
was found between the Manchester operation and VH groups 
in the subgroup analysis of the POP-Q stage III cases. The length 
of hospital stay and blood loss during the procedure were not 
significantly different between the Manchester operation and 
VH groups with preoperative POP-Q stage III. Manchester op-
eration had a shorter operation time of about 20 minutes than 
the VH procedure (p=0.006; Table 4).
Table 1. Baseline Characteristics of the 1:1 PS-Matched Data for Age, Parity, and Preoperative POP-Q Stage as Matching Variables
Manchester operation (n=20) Vaginal hysterectomy (n=20) p value
Age (yr)† 43.90±4.91 42.75±5.15 0.466
BMI (kg/m²)† 22.44±1.64 22.94±2.78 0.528
Parity‡ 2 (1–2) 2 (2–2) 0.200
Postmenopausal status* 1 (5) 3 (15) 0.157
Smoker* 0 (0) 1 (5) 0.317
Preoperative POP-Q stage* 0.564
Stage II 0 (0) 0 (0)
Stage III 19 (95) 18 (90)
Stage IV 1 (5) 2 (10)
Concurrent surgery*
Anterior colporrhaphy 6 (30) 12 (60) 0.058
Posterior colporrhaphy 20 (100) 20 (100) >0.999
Midurethral sling* 1 (5) 7 (35) 0.014
PS, propensity score; POP-Q, Pelvic Organ Prolapse Quantification; BMI, body mass index.
*Categorical variable, provided in n (%); †Continuous variable, provided in mean±standard deviation; ‡Continuous variable, provided in median (Q1–Q3).
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The results from second subgroup analysis of preoperative 
POP-Q stage III indicated high BMI [odds ratio (OR)=1.74; 95% 
confidence interval (CI), 1.08–2.81] and not having a concurrent 
anterior colporrhaphy to be significant risk factors (OR of con-
current anterior colporrhaphy=0.06; 95% CI, 0.01–0.75) for re-
currence of POP within 1 year after surgery. Age and parity failed 
to attain statistical significance in relation to recurrence of POP 
(Table 5).
No statistically significant difference in postoperative compli-
cation rate was observed between the Manchester operation and 
VH groups, either in the matched or unmatched data, although 
significant differences in the types of complications were found 
between the two groups. In the Manchester operation group, 
postoperative bleeding and cervical stenosis were major com-
Table 3. Baseline Characteristic of the 1:1 PS-Matched Data with Age, BMI and Parity as Matching Variables for Preoperative POP-Q Stage III Pa-
tients
Manchester operation (n=20) Vaginal hysterectomy (n=20) p value
Age (yr)† 42.65±4.72 42.80±4.43 0.817
BMI (kg/m²)† 22.53±1.69 22.70±2.46 0.821
Parity‡ 2 (1–2) 2 (2–2) 0.126
Postmenopausal status* 0 (0) 3 (15) 0.083
Smoker* 0 (0) 1 (5) 0.317
Concurrent surgery*
Anterior colporrhaphy 6 (30) 13 (65) 0.035
Posterior colporrhaphy 19 (95) 20 (100) 0.317
Midurethral sling* 1 (5) 8 (40) 0.020
PS, propensity score; BMI, body mass index; POP-Q, Pelvic Organ Prolapse Quantification.
*Categorical variable, provided in n (%); †Continuous variable, provided in mean±standard deviation; ‡Continuous variable, provided in median (Q1–Q3).
Table 4. Surgical Outcomes of the 1:1 PS-Matched Data with Age, BMI and Parity as Matching Variables for Preoperative POP-Q Stage III Patients
Manchester operation (n=20) Vaginal hysterectomy (n=20) p value
Recurrence of POP* 0 (0) 0 (0) >0.999
Length of hospital stay (day)† 5 (5–5) 5 (5–7) 0.229
Duration of operation (min)‡ 93.9±21.8 113.7±20.4 0.006
Blood loss during surgery (mL)† 0 (0–30) 0 (0–45) 0.976
Complication* 2 (10) 0 (0) 0.157
Infection (UTI, pneumonia, sepsis) * 0 (0) 0 (0) >0.999
Bleeding* 1 (50) 0 (0)
Iatrogenic organ injury 0 (0) 0 (0)
Heart failure 0 (0) 0 (0)
Hematometra* 1 (50) 0 (0)
PS, propensity score; BMI, body mass index; POP-Q, Pelvic Organ Prolapse Quantification; POP, pelvic organ prolapse; UTI, urinary tract infection.
*Categorical variable, provided in n (%); †Continuous variable, provided in median (Q1–Q3); ‡Continuous variable, provided in mean±standard deviation.
Table 2. Surgical Outcomes of the 1:1 PS-Matched Data with Age, Parity, and Preoperative POP-Q Stage as Matching Variables
Manchester operation (n=20) Vaginal hysterectomy (n=20) p value
Recurrence of POP* 0 (0) 1 (5) 0.317
Length of hospital stay (day)† 5 (5–5) 5 (5–6) 0.423
Duration of operation (min)‡ 95.3±20.2 109.1±20.7 0.033
Blood loss during surgery (mL)† 5 (0–30) 0 (0–50) 0.763
Complication* 2 (10) 0 (0) 0.157
Infection (UTI, pneumonia, sepsis) * 0 (0) 0 (0) >0.999
Bleeding* 1 (50) 0 (0)
Iatrogenic organ injury 0 (0) 0 (0)
Heart failure 0 (0) 0 (0)
Hematometra* 1 (50) 0 (0)
PS, propensity score; POP-Q, Pelvic Organ Prolapse Quantification; POP, pelvic organ prolapse; UTI, urinary tract infection.
p value from McNemar’s test and paired t-test, as appropriate.
*Categorical variable, provided in n (%); †Continuous variable, provided in median (Q1–Q3); ‡Continuous variable, provided in mean±standard deviation.
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plications, whereas the most common postoperative complica-
tion in the VH group was postoperative infection. Two iatrogenic 
organ injuries occurred in the VH group. One patient reported 
experiencing bladder injury, and the other patient had bowel 
injury during surgery. In the Manchester operation group, no 
organ damage occurred in the study period. In total study pop-
ulation, only one patient in the VH group experienced under-
lying heart failure aggravation after surgery, which was related 
to general anesthesia (Supplementary Table 1, only online).
DISCUSSION
The reported failure rates of Manchester operation range from 
0% to 50%.5-7,10 However, Tipton and Atkin included nonprolapse 
indication in the reoperation category,5 and some of the subjects 
in the study of de Boer, et al.6 were not patients with uterine pro-
lapse. In this study, the 1-year recurrence rate of Manchester op-
eration was 0%. This result suggests that the recurrence rate is 
extremely low if Manchester operation is performed for the ap-
propriate patients who present with true cervical elongation.
Currently, no consensus has been reached on the diagnosis 
of cervical elongation. Berger, et al.11 measured cervical length 
by using magnetic resonance imaging (MRI), but considering 
the high cost of MRI, whether MRI is necessary for diagnosis of 
cervical elongation is doubtful. In this study, we confirmed cer-
vical elongation by using the POP-Q system. In addition, in a re-
cent study, cervical length measured using the POP-Q system 
was more related to anatomical cervical length than that report-
ed in an imaging study.12 Moreover, measuring D point in the 
POP-Q system was necessary to differentiate between true cer-
vical elongation and uterine descent.13-15
The extent of Manchester operation is smaller than that of VH 
because the uterine body is not excised in Manchester opera-
tion. For this reason, the operation time for Manchester oper-
ation in our study was shorter than that for VH. This result is 
similar to those of previous studies.6-8,10 Although no significant 
difference in complication rate was found between the two 
groups, among the total study population, one patient who un-
derwent VH had complications related to general anesthesia, 
which is associated with the duration of anesthesia. In addition, 
two patients in the VH group reported organ damage near the 
uterus, whereas no organ damage was reported in the Man-
chester operation group. This result suggests that performing 
Manchester operation instead of VH can minimize damage to 
surrounding organs because Manchester operation is a less ex-
tensive procedure. A previous research reported that the compli-
cation rate of Manchester operation was lower than that of VH.7
Our study identified higher BMI and not receiving concur-
rent anterior colporrhaphy as posing a greater risk for POP re-
currence. We performed anterior colporrhaphy in the patients 
with anterior prolapse at the time of surgery. However, the an-
terior compartment of the women without anterior prolapse 
would have had some defects at the time of surgery because half 
of the support structures of the anterior compartment are in-
volved in apical support.16 Therefore, patients who underwent 
anterior colporrhaphy to reinforce the anterior support seemed 
to have a lower recurrence rate than those who did not. A simi-
lar tendency is expected for the relationship between concur-
rent posterior colporrhaphy and POP recurrence. However, the 
relationship between posterior colporrhaphy and POP recur-
rence was not statistically significant because 99.0% of preop-
erative POP-Q stage III patients underwent posterior colpor-
rhaphy in this study. In addition, at present, whether higher BMI 
is a risk factor of POP recurrence remains controversial.17
This study is the first to investigate the success rates of Man-
chester operation in patients with uterine prolapse caused by 
true cervical elongation. Using the POP-Q system, we identified 
true cervical elongation patients among women with uterine 
prolapse. Contrary to our research, previous studies did not pro-
Table 5. The Risk of 1-Year Recurrence Estimated from Logistic Regression Models for Preoperative POP-Q Stage III Patients
Univariable model (n=204) Multivariable model (n=204)
OR (95% CI) p value OR (95% CI) p value
Age 1.02 (0.94–1.10) 0.643 1.06 (0.95–1.18) 0.316
BMI 1.62 (1.14–2.31) 0.007 1.74 (1.08–2.81) 0.024
Parity 0.64 (0.26–1.60) 0.340 0.45 (0.13–1.63) 0.224
Postmenopausal status 2.97 (0.16–56.58) 0.469 - -
Smoker 11.89 (0.12–>999.99) 0.294* - -
Length of hospital stay 0.72 (0.33–1.60) 0.422 - -
Duration of operation 1.01 (0.96–1.05) 0.846 - -
Blood loss during surgery 0.54 (0.00–145.03) 0.829 - -
Anterior colporrhaphy 0.07 (0.01–0.67) 0.021 0.06 (0.01–0.75) 0.029
Posterior colporrhaphy 0.14 (0.00–6.31) 0.311* - -
Midurethral sling 2.16 (0.35–13.30) 0.408 - -
Complication 1.82 (0.08–41.11) 0.706* - -
POP-Q, Pelvic Organ Prolapse Quantification; OR, odds ratio; CI, confidence interval; BMI, body mass index.
*p value obtained from Firth bias-corrected logistic regression.
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vide indications for Manchester operation, or Manchester op-
eration was performed in accordance with the preference of sur-
geons or patients.5-8 Therefore, the success rate of Manchester 
operation in this study is more reliable than those reported in 
previous studies.
In addition, the subjects in our study were a better represen-
tation of actual clinical practice than the subjects described in 
earlier studies. The study populations in these studies included 
patients without uterine prolapse or patients with stage 0 or I 
who did not require surgery.6-8 In contrast, 98.9% of the study 
population in this study had advanced uterine prolapse. The 
research by Bergman, et al.7 excluded patients who underwent 
posterior colporrhaphy, while our study included patients who 
underwent anterior and posterior colporrhaphy and midure-
thral sling, which are frequently performed with surgery for 
uterine prolapse. Another strength of this study is that a more 
accurate and objective comparison of the outcomes of opera-
tion was possible because the patients in the Manchester op-
eration and VH groups were balanced in regards to age, parity, 
and preoperative POP-Q stage using PS matching.
This study has some limitations. The number of Manchester 
operation patients in this study was relatively smaller than the 
number of VH patients, owing to the strict criteria for true cervi-
cal elongation. We only investigated 1-year outcomes and fur-
ther research will be required to identify long-term outcomes 
of Manchester operation in patients with true cervical elonga-
tion. Finally, our research is not a prospective or randomized 
study, but a retrospective study.
In conclusion, the Manchester operation seems to be an ef-
fective procedure in terms of anatomical outcomes as compared 
with VH for uterine prolapse caused by true cervical elongation. 
We confirmed uterine prolapse using the C point and excluded 
uterine descent on the basis of the D point in the POP-Q sys-
tem. Identifying true uterine prolapse from uterine prolapse 
seems to be key to the success of the Manchester operation.
In addition, Manchester operation is a surgical procedure that 
meets patient demand for preservation of the uterus. There-
fore, if a patient presents with uterine prolapse caused by true 
cervical elongation and wants to preserve the uterus, Manches-
ter operation seems to be an effective and safe surgical option.
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